Generic placeholder image

Drug Design Reviews - Online (Discontinued)

Editor-in-Chief

ISSN (Print): 1567-2697
ISSN (Online): 1567-2697

Inhibitors of NMT: A New Class of Chemotherapeutic Drugs

Author(s): Gagan Bajaj, Anuraag Shrivastav, Ponniah Selvakumar, Mohammed Khysar Pasha, Yanjie Lu, Jonathan R Dimmock and Rajendra K Sharma

Volume 1, Issue 4, 2004

Page: [347 - 354] Pages: 8

DOI: 10.2174/1567269043390744

Price: $65

Abstract

Myristoyl-CoA:protein N-myristoyltransferase (NMT) is an enzyme that catalyzes the attachment of myristate to the N-terminus of a number of cellular proteins of signal transduction pathways which may be involved in oncogenesis, in secondary cellular signaling and in infectivity of retroviruses. NMT expression and activity have been found to be elevated in cancers of the stomach, colon and gallbladder as well as in some leukemia cell lines. NMT is proposed as a novel molecular target for anticancer drug design. There is a rapidly expanding body of synthetic chemical and endogenous NMT inhibitors and this review discusses the design and characterization of some inhibitors from our laboratory.

« Previous

Rights & Permissions Print Export Cite as
© 2024 Bentham Science Publishers | Privacy Policy